Nuwellis, Inc. NUWE
Regular-session close
After hours · Nov 20, 7:31 PM ET
- YTD
- -99.38%
- 1 year
- -99.48%
5D -1.31 (-28.17%)
- Market cap
- 1.84M
- Revenue (ttm)
- 9.01M
- Profit margin
- -232.24%
- EPS (ttm)
- 3,609.63
- Shares out
- 4.37M
- P/E ratio
- 0.00
- Forward P/E
- -0.41
- YTD return
- -99.38%
- 1-year return
- -99.48%
- Volume
- 9.19K
- Avg volume
- 829.43K
- Open
- 3.78
- Previous close
- 3.81
- Day's range
- 3.27 – 3.78
- 52-week range
- 2.88 – 1,319.85
- Beta
- 0.36
- Price target
- 16.00 (+369.2%)
- 50-day average
- 1.53
Key statistics
- 200-day average
- 5.15
- Enterprise value
- 2.30M
- Price / sales
- 0.51
- Price / book
- 0.06
- Revenue growth
- 5.70%
- Free cash flow
- -12.32M
- Total cash
- 1.02M
- Total debt
- 654.00K
- Return on equity
- -987.45%
- Short % of float
- 17.27%
Fundamental scorecard
8 of 25 checks passed on NUWE’s reported financials
8of 25 checks passed
- Value 2 of 5
- Growth 2 of 5
- Profitability 1 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 11, 2024 | Sep 1, 2024 | -0.88 | 1.74 | +2.62 | +297.73% |
| Aug 13, 2024 | Jun 1, 2024 | -9.49 | -18.85 | -9.36 | -98.63% |
| May 7, 2024 | Mar 1, 2024 | 0.00 | -20.98 | — | — |
| Mar 5, 2024 | Dec 1, 2023 | 0.00 | -78.32 | — | — |
| Nov 7, 2023 | Sep 1, 2023 | 0.00 | -63.29 | — | — |
| Aug 8, 2023 | Jun 1, 2023 | 0.00 | -127.62 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 2024 | Roth MKM | reit | Buy | Buy |
| Jul 29, 2024 | Roth MKM | init | — | Buy |
| Nov 8, 2023 | Ladenburg Thalmann | down | Buy | Neutral |
About Nuwellis, Inc.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- nuwellis.com
News
Nuwellis to Host Webinar Discussing ULTRA-Peds Registry Results and Aquadex Performance in Critically Ill Pediatric Patients
Nuwellis Q3 2026 Earnings Call Transcript Nuwellis Q3 EPS $(5.81) Misses $(0.39) Estimate, Sales $2.212M Miss $2.505M Estimate
Nuwellis Submits 510(k) Premarket Notification To FDA Seeking To Expand Indication Of Aquadex SmartFlow System To Include Pediatric Patients Weighing 5 Kg And Above
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session Nuwellis Has Received A Notice Of Allowance For A U.S. Patent Titled "BLOOD FILTRATION SYSTEM WITH INFUSION PUMP STATE DETECTOR".
Your note
Sign in to keep a note on NUWE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| JARAMILLO NESTOR JR, | Chief Executive Officer | Purchase | Mar 14, 2023 | 4,098 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| HRT Financial LP | 0.35% | 15,127 | 16.03K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.31% | 13,631 | 14.45K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.15% | 6,346 | 6.73K | Sep 29, 2024 |
| Morgan Stanley | 0.01% | 312 | 330 | Sep 29, 2024 |
| JP Morgan Chase & Company | 0.00% | 1 | 1 | Sep 29, 2024 |
| Bank of America Corporation | 0.00% | 11 | 11 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.17% | 7,478 | 7.93K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.07% | 3,189 | 3.38K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.06% | 2,759 | 2.92K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.03% | 1,426 | 1.51K | Sep 29, 2024 |
